Chung, S. S., Oliva, B., Dwabe, S., & Vadgama, J. V. (2016). Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol.
Styl ChicagoChung, Seyung S., Bryant Oliva, Sami Dwabe, a Jaydutt V. Vadgama. "Combination Treatment With Flavonoid Morin and Telomerase Inhibitor MST-312 Reduces Cancer Stem Cell Traits By Targeting STAT3 and Telomerase." Int J Oncol 2016.
Citace podle MLAChung, Seyung S., Bryant Oliva, Sami Dwabe, a Jaydutt V. Vadgama. "Combination Treatment With Flavonoid Morin and Telomerase Inhibitor MST-312 Reduces Cancer Stem Cell Traits By Targeting STAT3 and Telomerase." Int J Oncol 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..